FMC (NYSE:FMC) Updates Q1 2025 Earnings Guidance

FMC (NYSE:FMC) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.050-0.150 for the period, compared to the consensus earnings per share estimate of 0.790. The company issued revenue guidance of $750.0 million-$800.0 million, compared to the consensus revenue estimate of $951.8 million. FMC also updated its FY 2025 guidance to 3.260-3.700 EPS.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on FMC. Citigroup lifted their target price on FMC from $55.00 to $61.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 29th. Barclays raised shares of FMC from an “equal weight” rating to an “overweight” rating and set a $65.00 price objective for the company in a report on Tuesday, January 21st. KeyCorp reduced their price target on shares of FMC from $79.00 to $69.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Royal Bank of Canada increased their price objective on shares of FMC from $78.00 to $81.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. Finally, Mizuho decreased their target price on FMC from $70.00 to $55.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Ten research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, FMC currently has an average rating of “Hold” and a consensus price target of $63.75.

FMC Stock Performance

Shares of NYSE:FMC traded down $0.92 on Tuesday, hitting $54.00. The company’s stock had a trading volume of 4,028,292 shares, compared to its average volume of 1,559,641. FMC has a 12 month low of $47.71 and a 12 month high of $68.72. The stock’s 50-day moving average is $53.55 and its two-hundred day moving average is $58.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.09 and a current ratio of 1.48. The company has a market capitalization of $6.74 billion, a price-to-earnings ratio of 4.65, a price-to-earnings-growth ratio of 1.20 and a beta of 0.84.

FMC (NYSE:FMC) last released its quarterly earnings results on Tuesday, February 4th. The basic materials company reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.14. FMC had a net margin of 34.93% and a return on equity of 7.68%. On average, equities research analysts forecast that FMC will post 3.33 EPS for the current year.

FMC Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 16th. Shareholders of record on Tuesday, December 31st were given a $0.58 dividend. The ex-dividend date was Tuesday, December 31st. This represents a $2.32 dividend on an annualized basis and a yield of 4.30%. FMC’s dividend payout ratio (DPR) is 19.97%.

Insider Activity

In other news, EVP Michael Finian Reilly sold 2,958 shares of the stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $55.25, for a total value of $163,429.50. Following the completion of the sale, the executive vice president now owns 25,468 shares in the company, valued at $1,407,107. This represents a 10.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Jacqueline Scanlan sold 4,529 shares of FMC stock in a transaction on Monday, November 11th. The shares were sold at an average price of $59.67, for a total value of $270,245.43. Following the transaction, the vice president now owns 28,649 shares in the company, valued at $1,709,485.83. This represents a 13.65 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 7,491 shares of company stock worth $433,898. 0.81% of the stock is owned by company insiders.

About FMC

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control.